Automatic glucose readings, sent right to your
patients’ smartphones3,4 with the option of scanning to see readings
Glucose readings are sent directly to patients' smartphones3,4 every minute, of every hour, of every day for up to
14 days.
The only sensor-based glucose monitoring system that can fill in data gaps with a quick scan when Bluetooth®5
is unavailable.
With the LibreLinkUp app7, caregivers always have access to their loved ones' glucose data and can set their
own real-time glucose alarm notifications.7-9
The FreeStyle LibreLink App makes it easy for patients to share their glucose readings with you and their family
members.
Readings from the FreeStyle LibreLink app3 are automatically19 uploaded to LibreView14 for more informed patient
consultations and treatment decisions, while data can be shared with family members using LibreLinkUp.7
Patients can scan their sensor to fill in up to 8 hours of missing data, for a complete glucose history.
The FreeStyle Libre 2 system is proven to have significant clinical and real-world benefits for patients with diabetes.
95% of patients have a better
understanding of their glucose
fluctuations15
Proven to decrease HbA1c16,17
and increase Time in Range12,18
Reduces time spent in hypoglycaemia
by 38% in T1D18 and 43% in T2D12
compared to self-monitoring
of blood glucose
Optional glucose alarms available for the FreeStyle Libre 2 sensor, FreeStyle Libre 2 Plus sensor and the FreeStyle LibreLink app3 or FreeStyle Libre 2-reader let your patients know the minute their glucose is too low or too high13
Automatic glucose readings from the
FreeStyle Libre 2 and FreeStyle Libre 2 Plus sensors are sent
directly to patients’ smartphones.3,4
References & disclaimers
Images are for illustrative purposes only. Not real patients or data.
1. 60-minute warm-up required when applying the sensor.
2. Sensor is water resistant in up to 1 meter of water. Do not immerse longer than 30 minutes. Not to be used above 3048 meters.
3. The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check the website for more information about device compatibility before using the app. Use of FreeStyle LibreLink may require registration with LibreView.
4. Glucose readings are automatically displayed in the app only when the smartphone and sensor are connected and in range.
5. The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Abbott is under license.
6. Hilliard, M., et al. Diabetes Technology & Therapeutics. (2019): https:/doi.org/10.1089/dia.2019.0142.
7. The LibreLinkUp app is only compatible with certain mobile devices and operating systems. Please check www.librelinkup.com for more information about device compatibility before using the app. Use of LibreLinkUp requires registration with LibreView. The LibreLinkUp mobile app is not intended to be a primary glucose monitor: home users must consult their primary device(s) and consult a healthcare professional before making any medical interpretation and therapy adjustments from the information provided by the app.
8. The user’s device must have internet connectivity for glucose data to automatically upload to LibreView and to transfer to connected LibreLinkUp app users.
9. Unger J., Postgrad Med. (2020): https://doi.org/10.1080/00325481.2020.1744393
10. Alva, S. et al. J Diabetes Sci Technol (2022): https://doi.org/10.1177/1932296820958754.
11. Finger pricks are required when readings and alarms do not match symptoms or expectations.
12. Haak, T. et al. Diabetes Ther (2017): https://doi.org/10.1007/s13300-016-0223-6.
13. Notifications will only be received when alarms are turned on and the sensor is within 6 metres unobstructed of the reading device. You must have override do not disturb settings enabled to receive alarms and alerts on your smartphone.
14. The LibreView website is only compatible with certain operating systems and browsers. Please check www.LibreView.com for additional information.
15. Fokkert, M. et al. BMJ Open Diab Res Care (2019): https://doi.org/10.1136/bmjdrc-2019-000809.
16. Yaron, M. et al. Diabetes Care (2019): https://doi.org/10.2337/dc18-0166.
17. Leelarathna, L. et al. Engl J Med. (2022): https://doi.org/10.1056/NEJMoa2205650.
18. Bolinder, J. et al. Lancet (2016): https://doi.org/10.1016/S0140-6736(16)31535-5.
19. Sharing of glucose data requires registration with LibreView. Automatic upload requires a wireless internet connection or mobile data connection.
ADC-97337 v1 09/24
Alla oleva "Kyllä"-linkki vie sinut muulle kuin Abbott Laboratories -sivustolle. Linkit muille verkkosivustoille eivät ole Abbott Laboratoriesin hallinnassa, eikä Abbott Laboratories ole vastuussa tällaisten verkkosivustojen sisällöstä tai sellaisista linkeistä. Abbott Laboratories tarjoaa nämä linkit sinulle vain avuksi, eikä minkään linkin lisääminen tarkoita, että Abbott Laboratories hyväksyy sivuston.
Haluatko poistua tältä sivulta?
Tämä on tuotekohtainen verkkosivusto, joka on tarkoitettu vain terveydenhuollon ammattilaisille Suomessa. Jos asut toisessa maassa, ota yhteyttä paikalliseen Abbott-toimistoon saadaksesi maatasi koskevat oikeat tuotetiedot.
PYSY YHTEYDESSÄ